Membrane raftlysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin

Cardiovascular Research

Volumn 89, Issue 2, 2011, Pages 401-409

  Xia, Min ^a   Zhang, Chun ^a   Boini, Krishna M ^a   Thacker, Audrey M ^a   Li, Pin Lan ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Coronary artery; Lipid rafts; Oxidative stress; Sphingolipids; Transmembrane signalling

Indexed keywords

ADIPOCYTOKINE; CERAMIDE; FLUORESCENT DYE; FM1 43; GLYCOPROTEIN GP 91; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDE; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG; ADIPONECTIN; NEUTROPHIL CYTOSOLIC FACTOR 1; RECOMBINANT PROTEIN; SUPEROXIDE; VASODILATOR AGENT;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CARDIOVASCULAR DISEASE; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY; COW; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; LIPID RAFT; LYSOSOME; MEMBRANE FUSION; MEMBRANE TRANSPORT; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; CATTLE; CELL CULTURE; CELL MEMBRANE; CORONARY BLOOD VESSEL; DOSE RESPONSE; DRUG EFFECT; ELECTRON SPIN RESONANCE; ENZYMOLOGY; METABOLISM; OXIDATIVE STRESS; PROTEIN TRANSPORT; TIME;

ADIPONECTIN; ANIMALS; CATTLE; CELLS, CULTURED; CERAMIDES; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENDOTHELIAL CELLS; ENZYME ACTIVATION; LYSOSOMES; MEMBRANE FUSION; MEMBRANE MICRODOMAINS; MICROSCOPY, CONFOCAL; NADPH OXIDASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; SUPEROXIDES; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 78751475177     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq286     Document Type: Article

References (39)

1. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994;14:1431-1437.
2. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307: 426-430. (Pubitemid 40139988)
3. Sethi JK. Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome? Curr Hypertens Rep 2007;9:33-38.
4. Stephens JM, Vidal-Puig AJ. An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity. Curr Opin Lipidol 2006;17:128-131.
5. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K et al. Retraction. Science 2007;318:565.
6. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295-299.
7. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 2007;56:451-458.
8. Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T et al. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. Nephrol Dial Transplant 2008;23:959-965. (Pubitemid 351767576)
9. Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008;32:268-274.
10. Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J Atheroscler Thromb 2010;17:115-130.
11. Zoccali C. Endothelial dysfunction in CKD: a new player in town? Nephrol Dial Transplant 2008;23:783-785.
12. Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimburger O et al. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Am J Kidney Dis 2007;49: 237-244.
13. van der Veer E, Nong Z, O'Neil C, Urquhart B, Freeman D, Pickering JG. Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res 2005;97:25-34.
14. Fasshauer M, Bluher M, Stumvoll M, Tonessen P, Faber R, Stepan H. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf) 2007;66:434-439.
15. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009;22:1311-1319; quiz 1417-1318.
16. Shively CA, Register TC, Clarkson TB. Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation. Am J Primatol 2009;71: 742-751.
17. Zhang AY, Yi F, Zhang G, Gulbins E, Li PL. Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 2006;47:74-80.
18. Natoli G, Costanzo A, Guido F, Moretti F, Levrero M. Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. Biochem Pharmacol 1998; 56:915-920.
19. Bollinger CR, Teichgraber V, Gulbins E. Ceramide-enriched membrane domains. Biochim Biophys Acta 2005;1746:284-294.
20. Zhang DX, Yi FX, Zou AP, Li PL. Role of ceramide in TNF-alpha-induced impairment of endothelium-dependent vasorelaxation in coronary arteries. Am J Physiol Heart Circ Physiol 2002;283:H1785-1794.
21. Li PL, Zhang Y, Yi F. Lipid raft redox signaling platforms in endothelial dysfunction. Antioxid Redox Signal 2007;9:1457-1470.
22. Yi F, Jin S, Li PL. Lipid raft-redox signaling platforms in plasma membrane. Methods Mol Biol 2009;580:93-107.
23. Li PL, Gulbins E. Lipid rafts and redox signaling. Antioxid Redox Signal 2007;9: 1411-1415.
24. Touyz RM. Lipid rafts take center stage in endothelial cell redox signaling by death receptors. Hypertension 2006;47:16-18.
25. Jin S, Yi F, Zhang F, Poklis JL, Li PL. Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells. Arterioscler Thromb Vasc Biol 2008;28:2056-2062.
26. Jia SJ, Jin S, Zhang F, Yi F, Dewey WL, Li PL. Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes. Am J Physiol Heart Circ Physiol 2008;295: H1743-1752.
27. Jin S, Yi F, Li PL. Contribution of lysosomal vesicles to the formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal 2007;9:1417-1426. (Pubitemid 47255022)
28. Bao JX, Jin S, Zhang F, Wang ZC, Li N, Li PL. Activation of membrane NADPH oxidase associated with lysosome-targeted acid sphingomyelinase in coronary endothelial cells. Antioxid Redox Signal 2010;12:703-712.
29. Bao JX, Xia M, Poklis JL, Han WQ, Brimson C, Li PL. Triggering role of acid sphingomyelinase in endothelial lysosome-membrane fusion and dysfunction in coronary arteries. Am J Physiol Heart Circ Physiol 2010;298:H992-H1002.
30. Kowalska I, Straczkowski M, Nikolajuk A, Adamska A, Karczewska-Kupczewska M, Otziomek E et al. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 2007;22:1824-1829.
31. Goldstein R, Duvic M, Targoff IN, Reichlin M, McMenemy AM, Reveille JD et al. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum 1990;33:1240-1248.
32. Kim SR, Bae YH, Bae SK, Choi KS, Yoon KH, Koo TH et al. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys Acta 2008;1783:886-895.
33. Jin S, Zhang Y, Yi F, Li PL. Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol 2008;28:485-490.
34. Zhang AY, Yi F, Jin S, Xia M, Chen QZ, Gulbins E et al. Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal 2007;9:817-828.
35. Harata NC, Choi S, Pyle JL, Aravanis AM, Tsien RW. Frequency-dependent kinetics and prevalence of kiss-and-run and reuse at hippocampal synapses studied with novel quenching methods. Neuron 2006;49:243-256.
36. Zhang Z, Chen G, Zhou W, Song A, Xu T, Luo Q et al. Regulated ATP release from astrocytes through lysosome exocytosis. Nat Cell Biol 2007;9:945-953.
37. Yamawaki H, Hara N, Okada M, Hara Y. Visfatin causes endothelium- dependent relaxation in isolated blood vessels. Biochem Biophys Res Commun 2009;383:503-508.
38. Zhang AY, Teggatz EG, Zou AP, Campbell WB, Li PL. Endostatin uncouples NO and Ca2+ response to bradykinin through enhanced O2 production in the intact coronary endothelium. Am J Physiol Heart Circ Physiol 2005;288:H686-H694.
39. Riethmuller J, Riehle A, Grassme H, Gulbins E. Membrane rafts in host-pathogen interactions. Biochim Biophys Acta 2006;1758:2139-2147.